Excerpts from RHB report

Analyst: Jarick Seet

Profit Margins Continue To Improve; BUY
Maintain BUY and DCF-based TP of SGD0.30, 20% upside and c.7% yield. As at 9M20, Fu Yu Corp had SGD97.8m net cash with zero borrowings, despite COVID-19 affecting production.

FU YU

Share price: 
25 c

Target: 
30 c

With further streamlining of its operations in China, despite lower revenue due to the closing of its Chongqing factory, we expect further cost savings ahead.

9M20 GPM also expanded to 23.5% from 18.0% in 9M19.

We expect the company to tide through the pandemic with attractive yields.



9M20 PATMI surged 36.7% YoY despite a 23.4% drop in revenue, mainly due the higher GPM. This can be attributed mainly to the change in revenue mix, a reduction in headcount, as well as the group’s ongoing initiatives to sustain costs and raise operational efficiencies.

FuYu machine1.20Fu Yu produces parts for products in various industries. Photo: CompanyGPM continued to improve to 23.5% from 18.0% a year ago.

With challenging business conditions expected ahead, management will continue to evaluate avenues to further rightsize and optimise its manufacturing operations in China to ensure it is better positioned for long-term business sustainability, ie by closing its Chongqing factory, which will likely provide further cost savings operationally.

Strong net cash; Attractive yield. As at 1H20, Fu Yu had a strong net cash position of SGD97.8m and zero borrowings.

It has also maintained an interim dividend payout.

We expect a 1.7 SG cents payout for FY20F, which should result in an attractive yield of 6.5%.

With management learning from past mistakes during the manufacturing crisis, its prudent approach has led to the company having a net cash balance sheet representing close to 53% of its market cap.

Coupled with its rich cash flow generation, we believe that it will be able to weather this storm, and come out stronger than its competitors.

Still one of our Top Picks; Stable and resilient. With further new projects in the medical and consumer and automotive fronts, we expect positive growth momentum for 4Q20F.

JarickSeet3.18Jarick Seet, analystDespite a blip in FY20F caused by the pandemic, we believe that Fu Yu – with its strong net cash balance sheet – will able to weather the storm, and at the same time, reward investors with attractive dividends going forward, despite a temporary drop in FY20F profits.

As a result, we maintain BUY and our DCF-based SGD0.30 TP.

The company is also an attractive target for privatisation or acquisition.

Key risks to our call: Economic slowdown, worsening trade war, and increasing COVID-19 cases.


Full report here. 

Counter NameLastChange
AEM Holdings2.3700.030
Best World2.460-
Boustead Singapore0.945-0.015
Broadway Ind0.133-
China Aviation Oil (S)0.920-0.005
China Sunsine0.4200.005
ComfortDelGro1.480-
Delfi Limited0.895-
Food Empire1.260-
Fortress Minerals0.300-0.005
Geo Energy Res0.305-0.005
Hong Leong Finance2.500-
Hongkong Land (USD)3.1400.020
InnoTek0.5500.030
ISDN Holdings0.305-0.005
ISOTeam0.0440.001
IX Biopharma0.0420.001
KSH Holdings0.250-
Leader Env0.047-0.004
Ley Choon0.045-
Marco Polo Marine0.067-
Mermaid Maritime0.139-0.001
Nordic Group0.305-0.005
Oxley Holdings0.088-0.001
REX International0.133-0.003
Riverstone0.795-0.020
Southern Alliance Mining0.430-
Straco Corp.0.485-0.025
Sunpower Group0.2100.005
The Trendlines0.067-
Totm Technologies0.022-
Uni-Asia Group0.820-0.005
Wilmar Intl3.470-0.030
Yangzijiang Shipbldg1.740-0.010